Zimmer Biomet (ZBH) CAO gains shares via RSU vesting and tax withholding

Rhea-AI Filing Summary

ZIMMER BIOMET HOLDINGS, INC. executive Paul A. Stellato, VP, Controller and Chief Accounting Officer, reported routine equity compensation activity. On March 6, 2026, restricted stock units covering 1,363 shares and 607 shares were converted into the same number of shares of common stock.

To cover related tax withholding on these vestings, the company retained 633 shares and 282 shares of common stock at $92.54 per share, as described in the footnotes. After these transactions, Stellato directly held 5,582 shares of Zimmer Biomet common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stellato Paul A

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Controller, CAO

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		1,363	A	$0	5,890	D
Common Stock	03/06/2026		F		633(1)	D	$92.54	5,257	D
Common Stock	03/06/2026		M		607	A	$0	5,864	D
Common Stock	03/06/2026		F		282(1)	D	$92.54	5,582	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/06/2026		M			1,363	03/06/2026	03/06/2026	Common Stock	1,363	$0	0	D
Restricted Stock Units	(2)	03/06/2026		M			607	03/06/2026	03/06/2026	Common Stock	607	$0	0	D

Explanation of Responses:

1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

2. Each RSU represents a contingent right to receive one share of Company common stock.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Paul A. Stellato (power of attorney previously filed)	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zimmer Biomet (ZBH) executive Paul Stellato report on this Form 4?

Paul Stellato reported RSU vesting transactions converting restricted stock units into common shares. The filing also shows shares withheld by Zimmer Biomet to satisfy tax obligations, resulting in updated direct ownership of 5,582 common shares.

How many Zimmer Biomet (ZBH) shares were acquired through RSU conversion?

Restricted stock units for 1,363 shares and 607 shares vested and converted into Zimmer Biomet common stock. In total, 1,970 shares were acquired through these RSU conversions as part of routine equity compensation.

How many Zimmer Biomet (ZBH) shares were withheld for taxes in this filing?

Zimmer Biomet withheld 633 shares and 282 shares of common stock to satisfy tax withholding obligations on RSU vesting. The withholding price was $92.54 per share, according to the reported transactions and footnotes.

What is Paul Stellato’s direct Zimmer Biomet (ZBH) share ownership after these transactions?

Following the RSU conversions and tax-withholding share dispositions, Paul Stellato directly owns 5,582 shares of Zimmer Biomet common stock. This figure reflects his updated direct holdings after all reported transactions on March 6, 2026.

Were any open-market buys or sells of Zimmer Biomet (ZBH) stock reported?

No open-market purchases or sales were reported. The Form 4 shows RSU conversions coded as M and tax-withholding dispositions coded as F, which are compensation and tax events rather than discretionary market trades.

How are the Zimmer Biomet (ZBH) restricted stock units structured in this Form 4?

Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet common stock. When the RSUs vested on March 6, 2026, they converted into common shares, subject to share withholding to cover tax obligations.